Vatiquinone | m-entrepreneurship.com

Product Name :
Vatiquinone

Search keywords :
EPI-743

drugId :
null

Target Vo:
Quinone reductase 1

Target Vo Short Name :
NQO1

Moa_Name:
Quinone reductase 1 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Edison Pharmaceuticals Inc

Active Company_Name :
National Human Genome Research Institute

Active Indication_Name:
Friedreich Ataxia

In Active Indication_Name:
Rett Syndrome

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TWIST Antibody
Phospho-mTOR (Ser2481) Antibody
Glutamine Synthetase Antibody (YA751): Glutamine Synthetase Antibody (YA751) is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to Glutamine Synthetase. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts